HCA Healthcare, Inc. HCA
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Andrew Mok |
Barclays |
505.84 $ |
551 $ |
45.16 % |
28/01/2026 |
| Stephen Baxter |
Wells Fargo |
483.6 $ |
452 $ |
-31.60 % |
07/01/2026 |
| Raj Kumar |
Stephens |
447.04 $ |
500 $ |
52.96 % |
27/10/2025 |
| Ben Hendrix |
RBC Capital |
447.04 $ |
482 $ |
34.96 % |
27/10/2025 |
| Scott Fidel |
Goldman Sachs |
452.23 $ |
520 $ |
67.77 % |
27/10/2025 |
| Sarah James |
Raymond James |
454.58 $ |
525 $ |
70.42 % |
27/10/2025 |
| Ben Hendrix |
RBC Capital |
334.29 $ |
401 $ |
66.71 % |
28/07/2025 |
| Craig Hettenbach |
Morgan Stanley |
373.01 $ |
410 $ |
36.99 % |
09/06/2025 |
| Andrew Mok |
Barclays |
382.16 $ |
416 $ |
33.84 % |
02/06/2025 |
| Matthew Gillmor |
KeyBanc |
308.21 $ |
370 $ |
61.79 % |
07/01/2025 |
| Michael Wiederhorn |
Oppenheimer |
359.07 $ |
400 $ |
40.93 % |
28/10/2024 |
| Matthew Gillmor |
KeyBanc |
359.07 $ |
420 $ |
60.93 % |
28/10/2024 |
| Ann Hynes |
Mizuho Securities |
359.16 $ |
425 $ |
65.84 % |
28/10/2024 |
| Matthew Gillmor |
KeyBanc |
387.25 $ |
475 $ |
87.75 % |
10/10/2024 |
| Pito Chickering |
Deutsche Bank |
406.01 $ |
441 $ |
34.99 % |
01/10/2024 |
| David MacDonald |
Truist Financial |
373.77 $ |
430 $ |
56.23 % |
19/08/2024 |
| Pito Chickering |
Deutsche Bank |
335.04 $ |
375 $ |
39.96 % |
28/06/2024 |
| Brian Tanquilut |
Jefferies |
336.82 $ |
390 $ |
53.18 % |
06/06/2024 |
| Ben Hendrix |
RBC Capital |
311.07 $ |
329 $ |
17.93 % |
29/04/2024 |
| Michael Wiederhorn |
Oppenheimer |
306.69 $ |
345 $ |
38.31 % |
29/04/2024 |
| Pito Chickering |
Deutsche Bank |
327.25 $ |
359 $ |
31.75 % |
12/04/2024 |
| Michael Wiederhorn |
Oppenheimer |
285.91 $ |
310 $ |
24.09 % |
24/04/2023 |
| Ben Hendrix |
RBC Capital |
285.91 $ |
315 $ |
29.09 % |
24/04/2023 |
| Ann Hynes |
Mizuho Securities |
285.91 $ |
298 $ |
12.09 % |
24/04/2023 |
| Ann Hynes |
Mizuho Securities |
213.47 $ |
230 $ |
16.53 % |
16/08/2022 |
| Joseph France |
Loop Capital Markets |
171.56 $ |
240 $ |
68.44 % |
16/06/2022 |
| Matt Borsch |
BMO Capital |
219.06 $ |
240 $ |
20.94 % |
28/04/2022 |
| Steve Baxter |
Wells Fargo |
210.5 $ |
227 $ |
16.50 % |
25/04/2022 |
| Sarah James |
Barclays |
210.64 $ |
256 $ |
45.36 % |
22/04/2022 |
| Ann Hynes |
Mizuho Securities |
210.64 $ |
290 $ |
79.36 % |
22/04/2022 |
| David S Macdonald |
Truist Financial |
258.43 $ |
310 $ |
51.57 % |
05/01/2022 |
| Brian Tanquilut |
Jefferies |
259.72 $ |
310 $ |
50.28 % |
04/01/2022 |
| Lisa Gill |
J.P. Morgan |
246.51 $ |
270 $ |
23.49 % |
21/12/2021 |
| Ann Hynes |
Mizuho Securities |
245.1 $ |
290 $ |
44.90 % |
20/12/2021 |
| John Ransom |
Raymond James |
240.42 $ |
300 $ |
59.58 % |
26/10/2021 |
| Michael Wiederhorn |
Oppenheimer |
240.83 $ |
290 $ |
49.17 % |
25/10/2021 |
| Pito Chickering |
Deutsche Bank |
240.83 $ |
306 $ |
65.17 % |
25/10/2021 |
| Sarah James |
Barclays |
244.85 $ |
275 $ |
30.15 % |
16/08/2021 |
| Jasper Hellweg |
Argus Research |
249.51 $ |
275 $ |
25.49 % |
02/08/2021 |
| Justin Lake |
Wolfe Research |
206.85 $ |
224 $ |
17.15 % |
21/06/2021 |